Dexrazoxane Injection, Powder, Lyophilized, For Solution
Product Images NDC 0143-9247

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Dexrazoxane (NDC 0143-9247). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Dexrazoxane For Injection 1)

Chemical structure diagram of Dexrazoxane, showing its molecular framework with two fused bicyclic ring systems and functional groups consistent with the active pharmaceutical ingredient dexrazoxane.*

FDA Label Image

Figure 1 (Dexrazoxane For Injection 2)

Bar graph showing the number of patients by cumulative dose of doxorubicin (mg/m²). The graph compares two treatment groups: FAC/Dexrazoxane (white bars) and FAC (black bars), displaying patient counts across dose intervals from 350 to 1000+ mg/m².*

FDA Label Image

250 mg Vial Label (Dexrazoxane For Injection 3)

Dexrazoxane for Injection 250 mg/vial, lyophilized powder for intravenous use, sterile and pyrogen-free, in a single-dose vial. The label includes storage instructions, reconstitution guidelines, and a warning that it is for intravenous use only and not to be administered subcutaneously. Distributed by West-Ward, USA, and manufactured by THYMOORGAN PHARMAZIE GmbH, Germany.*

FDA Label Image

Representative Carton Serialization Image (Dexrazoxane For Injection 4)

A product label featuring a 2D Data Matrix barcode and printed text including lot number (ABCDE12345), expiration date (MMMYYYY), GTIN (00301234567896), and serial number (12345678901234). The label is for Dexrazoxane injection, powder, lyophilized, for solution, used intravenously, and distributed by Hikma Pharmaceuticals USA Inc.*

FDA Label Image

500 mg Vial Label (Dexrazoxane For Injection 5)

Dexrazoxane for Injection 500 mg/vial, lyophilized powder for intravenous use, sterile and pyrogen-free, supplied as a single-dose vial. Label shows storage instructions, dilution and administration guidelines, and manufacturer information for Hikma Pharmaceuticals USA Inc.*

FDA Label Image

Representative Carton Serialization Image (Dexrazoxane For Injection 6)

Label on Dexrazoxane injection powder vial showing standardized identifiers including GTIN, serial number (SN), expiration date placeholder (EXP), and lot number (LOT). The label features a QR code for scanning these details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.